Drug Metabolism & Pharmacokinetics, Biogen, 225 Binney St, Cambridge, MA 02142, USA.
Current address: Denali Therapeutics, 161 Oyster Point Blvd., South San Francisco, CA 94080, USA.
Bioanalysis. 2024;16(15):791-800. doi: 10.1080/17576180.2024.2368339. Epub 2024 Jul 23.
Antisense oligonucleotides (ASOs) have been conjugated to various moieties, such as peptides, antibodies or Fab regions of antibodies, to enhance their delivery to target tissues. The quantitation of free ASO (ASO payload) is critical to characterize its pharmacokinetics/pharmacodynamics (PK/PD) properties and biodistribution after delivery of the peptide/antibody/Fab ASO conjugates. We developed a hybridization-based LC-MS/MS methodology for quantification of free ASO in tissues in the presence of Fab-ASO and ASO with linker (ASO-linker). The developed method was applied to measure accurately the free ASO concentrations in liver and gastrocnemius in mice that were dosed with Fab-ASO. This methodology has also been applied to free ASO bioanalysis for other antibody-ASO and Fab-ASO conjugates in various tissues and plasma/serum samples.
反义寡核苷酸 (ASO) 已与各种部分缀合,例如肽、抗体或抗体的 Fab 区域,以增强其递送至靶组织的能力。定量游离的 ASO(ASO 有效载荷)对于描述其药代动力学/药效学 (PK/PD) 特性和肽/抗体/Fab ASO 缀合物递送后的生物分布至关重要。我们开发了一种基于杂交的 LC-MS/MS 方法,用于在 Fab-ASO 和带有接头的 ASO(ASO-linker)存在的情况下定量组织中的游离 ASO。该方法已应用于测量经 Fab-ASO 给药的小鼠肝和比目鱼肌中游离 ASO 的浓度。该方法还应用于其他抗体-ASO 和 Fab-ASO 缀合物在各种组织和血浆/血清样本中的游离 ASO 生物分析。
AAPS PharmSciTech. 2024-10-10
Nucleic Acids Res. 2023-7-7
Eur Heart J Cardiovasc Pharmacother. 2022-12-15
Nucleic Acid Ther. 2022-8
Pharmaceutics. 2022-1-22